Unbiased AI-powered news
1 stories related to this topic, newest first.
fastcompany.comA clinical trial at Northwestern University found that adults taking once-daily oral aleniglipron lost an average of nearly 12 percent of body weight after 36 weeks. The drug is still in development and has not received FDA approval.